Mavyret 100-40 MG tablet 84S
Ended Awarded
- Contract number
- SPE2DB25FBE19
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,825
Award facts
- Contract value 100% obligated
- $11,825.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,825.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 84 tablets of MAVYRET 100-40 mg. The contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp operates as a major pharmaceutical distributor serving military and veteran healthcare systems through the DLA Medical Supply Chain. The company's federal procurement portfolio encompasses a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. MAVYRET, a direct-acting antiviral combination therapy, is consistent with AmerisourceBergen's role in supplying specialized pharmaceutical products to support federal healthcare programs. The parent SPE2DX IDC serves as a flexible global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide, with customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FBE19?
SPE2DB25FBE19 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FBE19 worth?
The government has obligated $11,825 on SPE2DB25FBE19.
Is contract SPE2DB25FBE19 an order under another contract?
Yes. SPE2DB25FBE19 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBE19 competed?
The extent of competition for SPE2DB25FBE19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award